Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IDegLira (REMIT IDegLira): A Randomized Controlled Trial

NCT03862716 is registered in ClinicalTrials.gov with Population Health Research Institute as lead sponsor.

NCT NCT03862716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03862716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IDegLira (REMIT IDegLira): A Randomized Controlled Trial
Lead sponsor
Population Health Research Institute
Phase
Phase 3
Overall status
Completed
Start date
April 23, 2019
Completion date
July 31, 2023
Enrollment
159 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus